Frolova E A, Tsarichenko D G, Saenko V S, Rapoport L M
Research Institute for Uronephrology and Human Reproductive Health, I.M. Sechenov First MSMU of Minzdrav of Russia MSU Moscow, Russia.
Urologiia. 2018 Dec(5):146-152.
Urolithiasis is a widespread chronic disease; its prevalence has been steadily increasing over the past 50 years. Urolithiasis accounts for a large proportion urologic diseases, exceeded only by urinary tract infections and diseases of the prostate. Urate urolithiasis refers to a type of urolithiasis, characterized by the formation of kidney stones consisting of uric acid or its salts. In populations of industrialized countries, uric acid is the second or third most frequently occurring stone-forming substance. The article summarizes the data on the global prevalence of both urolithiasis as a whole and urate urolithiasis in particular. The authors provide a detailed overview of the formation of the current concept of the urate urolithiasis pathogenesis and the management of the disease. The main focus is placed on the possibilities and the role of litholytic (stone-dissolving) therapy for urate urolithiasis and the mechanisms of the action of citrate preparations.
尿石症是一种广泛存在的慢性疾病;在过去50年里其患病率一直在稳步上升。尿石症在泌尿系统疾病中占很大比例,仅次于尿路感染和前列腺疾病。尿酸盐尿石症是尿石症的一种类型,其特征是形成由尿酸或其盐类组成的肾结石。在工业化国家的人群中,尿酸是第二或第三常见的结石形成物质。本文总结了关于尿石症总体以及特别是尿酸盐尿石症的全球患病率的数据。作者详细概述了尿酸盐尿石症发病机制和疾病管理的当前概念的形成。主要重点放在尿酸盐尿石症溶石(结石溶解)治疗的可能性和作用以及柠檬酸盐制剂的作用机制上。